A Two-Part Study Evaluating the Combination of Tazemetostat and CPX-351 (part 1) and Palbociclib with CPX-351 (part 2) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
BLOOD（2023）
关键词
DNA
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要